8-K: Syra Health Corp. Annual Meeting Results

Syra Health Corp. announced the results of its Annual Meeting of Stockholders held on July 23, 2026, detailing director elections, auditor ratification, and equity incentive plan amendments.

Summary

• Syra Health Corp. held its Annual Meeting of Stockholders on July 23, 2026.
• A quorum was established with 13,664,105 shares of common stock represented.
• All five director nominees were elected to serve until the 2027 Annual Meeting.
• The appointment of M&K CPAs, PLLC as the independent registered public accounting firm for fiscal year 2026 was ratified.
• An amendment to the 2022 Omnibus Equity Incentive Plan, increasing available Class A shares to 4,100,000, was approved.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine corporate governance and shareholder approvals that are generally expected and do not indicate significant new developments or challenges.

Positives

• All five director nominees were elected, indicating shareholder confidence in the current board.
• The appointment of the independent auditor was ratified with strong support.
• The amendment to the equity incentive plan was approved, potentially allowing for future employee and executive compensation and retention.

Future Outlook

The approval of the equity incentive plan amendment suggests a focus on future employee incentives and potential stock-based compensation, which could impact future financial performance and shareholder value.

Industry Context

StockSavvy.ai notes that annual meetings are standard corporate events for shareholder engagement and governance. The approval of equity incentive plans is common practice for companies seeking to attract and retain talent in the competitive healthcare technology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: Reaffirmed confidence in board leadership and provided mechanisms for future equity compensation.
• Employees: Potential for increased equity-based incentives through the amended plan.
• Management: Enhanced ability to use equity as a compensation tool.

Next Steps

• Directors elected will serve until the 2027 Annual Meeting of Stockholders.
• M&K CPAs, PLLC will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
• The company can now issue up to 4,100,000 Class A shares under the amended 2022 Omnibus Equity Incentive Plan.

Key Dates

Keywords

Annual Meeting, Stockholder Vote, Director Election, Independent Auditor, Equity Incentive Plan, Corporate Governance